Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2021-04-06

Clinical Trial Update: Hydration Based on Thoitaine, Aloe Vera and Calendula, in the Prevention of Hand-Foot Syndrome in Patients Using Capecitabine [Phase 2]

View source ↗

Summary

Phase 2 study evaluating hydration regimens with Thoitaine, Aloe Vera, and Calendula to prevent Hand-Foot Syndrome in patients treated with capecitabine.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Aloe vera (Aloe vera)
  • Calendula
  • Capecitabine (capecitabine)
  • Thoitaine

Snippet

Sponsor: Instituto Brasileiro de Controle do Cancer | Conditions: Hand-foot Syndrome | Phase 2 | Status: UNKNOWN